Search:  
   
 
NEWS
   

 

 
  Mennen Medical Receives FDA 510K for Horizon Angio-Intervention Radiology monitoring and reporting system
   
 

Mennen Medical has received FDA approval to market its innovative Horizon Angio patient monitoring and documentation system to the interventional cardiology and radiology market. Introducing a new dimension in patient care and documentation, Horizon Angio is a computerized medical device that analyzes a full range of patient physiological parameters during interventional peripheral arterial analysis procedures, while performing a complete spectrum of monitoring functions.

Specifically designed for the interventional cardiologist and radiologist, the innovative system provides a cost-effective, efficient and convenient method to document and monitor all peripheral angiography procedures. Making the Horizon Angio a stand-out in the industry, its measurement and documentation capabilities include a full set of peripheral diagrams with visual stenosis depiction. These include head, neck, leg and arm right and left sides, carotid, trunk and renal diagrams.

In today's fast-paced medical environment, acquiring accurate patient data and complete electronic documentation is vital. The Horizon Angio uses the latest patient monitoring technology and electronic documentation to meet these needs.
Statistical reporting, custom physician reports, ADT interfacing, HL7 and XML data exports are just a few of the extra tools available to make Horizon Angio an clinically significant addition to the department. Integrated with the complete line of Mennen Medical products, the Horizon Angio is a powerful tool for the interventional cardiologist and radiologist.
The Horizon Angio continues Mennen Medical's forty year tradition of exciting innovation.